Directory

>

Nina Kola

Nina Kola

Vice President, Medical Safety Assessment Therapeutic Area Head, Hematology and Oncology | Bristol Myers Squibb

Pennington, New Jersey, United States

View contact details (it's free)

Nina Kola

Summary

Nina Kola is an accomplished executive in the pharmaceutical industry, currently serving as the Vice President and Therapeutic Area Head for Medical Safety Assessment in Hematology and Oncology at Bristol Myers Squibb. With a robust background in medical safety assessment and pharmacovigilance, Nina has held various leadership positions at Bristol Myers Squibb, demonstrating a strong commitment to patient safety and innovative treatment solutions. Her extensive experience spans over 15 years in the pharmaceutical sector, including roles at Amgen and Takeda. Nina's strategic vision and leadership have significantly contributed to the advancement of medical safety practices within her organizations. She is known for her ability to navigate complex regulatory landscapes and foster collaborative relationships across multidisciplinary teams. Nina is passionate about driving advancements in oncology therapies and improving patient outcomes through rigorous safety assessments. Her journey reflects a dedication to bridging science and patient care, making her a respected leader in her field.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Leadership Development

Emerging Technologies

Organisational experience

Corporate Experience

Nina Kola

Work Experience

company logo

Vice President, Medical Safety Assessment Therapeutic Area Head, Hematology and Oncology at

Bristol Myers Squibb

August 2024 - Present

company logo

Vice President, Head Medical Safety Assessment Oncology at

Bristol Myers Squibb

January 2024 - August 2024

company logo

Vice President, Head Medical Safety Assessment Cardiovascular and Mature Products at

Bristol Myers Squibb

July 2022 - January 2024

company logo

Executive Director, Medical Safety Assessment Therapeutic Area Lead, Solid Tumor Oncology at

Bristol Myers Squibb

September 2020 - July 2022

company logo

Group Medical Director, Medical Safety Assessment Therapeutic Area Lead, Solid Tumor Oncology at

BRISTOL MYERS SQUIBB FARMACEUTICA

February 2020 - September 2020

company logo

Medical Director, Medical Safety Assessment Physician, Immuno-Oncology at

Bristol Myers Squibb

February 2015 - February 2020

company logo

Global Safety Director at

Amgen, Inc.

February 2013 - November 2014

company logo

Medical Director, Pharmacovigilance at

TAKEDA DEVELOPMENT CENTRE EUROPE LTD.

August 2011 - January 2013

company logo

Associate Medical Director, Pharmacovigilance at

Takeda Pharmaceuticals America, Inc.

June 2009 - September 2011

company logo

Medical Adviser then Senior Patient Safety Physician at

Pfizer, Inc.

January 2005 - January 2009

Logos provided by Logo.dev

Frequently Asked Questions about Nina Kola

What is Nina Kola email address?

Nina Kola's primary email address is ******@tgrd.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Nina Kola work for?

Nina Kola is a Vice President, Medical Safety Assessment Therapeutic Area Head, Hematology and Oncology at Bristol Myers Squibb, a company specializing in Biological products, except diagnostic.

How can I directly contact Nina Kola?

To contact Nina Kola directly, you can use the email address ******@tgrd.com. Complete contact information is available upon registration with Muraena.

Who is Nina Kola?

Nina Kola is an accomplished executive in the pharmaceutical industry, currently serving as the Vice President and Therapeutic Area Head for Medical Safety Assessment in Hematology and Oncology at Bristol Myers Squibb. With a robust background in medical safety assessment and pharmacovigilance, Nina has held various leadership positions at Bristol Myers Squibb, demonstrating a strong commitment to patient safety and innovative treatment solutions. Her extensive experience spans over 15 years in the pharmaceutical sector, including roles at Amgen and Takeda. Nina's strategic vision and leadership have significantly contributed to the advancement of medical safety practices within her organizations. She is known for her ability to navigate complex regulatory landscapes and foster collaborative relationships across multidisciplinary teams. Nina is passionate about driving advancements in oncology therapies and improving patient outcomes through rigorous safety assessments. Her journey reflects a dedication to bridging science and patient care, making her a respected leader in her field.

Nina`s contact details

mail

******@tgrd.com

*********@bms.com

Colleagues

avatar
Nicole Glazer

Vice President Informatics & Predictive Sciences at Bristol Myers Squibb

avatar
Nicole Starace

Executive Director, US Hematology Marketing

avatar
Sarah Chang

Executive Director, Clinical Data Acquisition

avatar
Nina Goworek

Vice President, Head of Worldwide Commercialization Strategy & Operations

avatar
Niv Gulati

Vice President, Cell Therapy Commercial Organization

avatar
Noel Heaney

VP External Manufacturing Biologics

avatar
Obiora Nnoli

Associate Director, Commercial Data Science & Decision Analytics

avatar
Sean Connolly

Executive Director Head of Clinical Evaluation and Collaborations, Immunology and Fibrosis

avatar
Seemi Kazmi

Executive Director, Digital Health TA Lead - Cardiovascular and Neuroscience

Ankur Shankhdhar

VP, US Commercialization Analytics

View Contact details (it's free)
Request Profile Removal